AK Medical (HKG:1789) said it intends to conduct on-market share repurchases of up to HK$150 million under its general mandate, according to a Monday Hong Kong bourse filing.
The mandate allows the company to buy back up to about 112.3 million shares, or 10% of its issued share capital, as at the June 18, 2025, annual general meeting.
The repurchases will be funded by internal resources, and all bought-back shares will be cancelled, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.